Croda Europe gains EXCiPACT certification at sites at Rawcliffe Bridge and Thorne in the UK
The first UK site to receive certification
Croda Europe, based in Goole, UK, has received an EXCiPACT certificate from SGS ICS France, one of EXCIPACT’s internationally-recognised certification bodies.
The certificate demonstrates that the Croda sites at Rawcliffe Bridge and Thorne near Goole manufacture and distribute pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standards.
This is the first UK site to receive certification and the 10th globally to date. The other sites are in Canada, France, Germany, The Netherlands and Saudi Arabia.
EXCiPACT is a voluntary international certification scheme designed and developed to assure cGMP and cGDP standards are being used in the manufacture and supply of pharmaceutical excipients.